Analysis of Investments
Adjustment to Net Income (Loss): Mark to Market Available-for-sale Securities
Abbott Laboratories, adjustment to net earnings
US$ in millions
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).
Adjusted Profitability Ratios: Mark to Market Available-for-sale Securities (Summary)
Abbott Laboratories, adjusted profitability ratios
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).
Profitability ratio | Description | The company |
---|---|---|
Adjusted net profit margin | An indicator of profitability, calculated as adjusted net income divided by revenue. | Abbott Laboratories’s adjusted net profit margin ratio improved from 2017 to 2018 and from 2018 to 2019. |
Adjusted ROE | A profitability ratio calculated as adjusted net income divided by shareholders’ equity. | Abbott Laboratories’s adjusted ROE improved from 2017 to 2018 and from 2018 to 2019. |
Adjusted ROA | A profitability ratio calculated as adjusted net income divided by total assets. | Abbott Laboratories’s adjusted ROA improved from 2017 to 2018 and from 2018 to 2019. |
Abbott Laboratories, Profitability Ratios: Reported vs. Adjusted
Adjusted Net Profit Margin
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).
2019 Calculations
1 Net profit margin = 100 × Net earnings ÷ Net sales
= 100 × 3,687 ÷ 31,904 = 11.56%
2 Adjusted net profit margin = 100 × Adjusted net earnings ÷ Net sales
= 100 × 3,687 ÷ 31,904 = 11.56%
Profitability ratio | Description | The company |
---|---|---|
Adjusted net profit margin | An indicator of profitability, calculated as adjusted net income divided by revenue. | Abbott Laboratories’s adjusted net profit margin ratio improved from 2017 to 2018 and from 2018 to 2019. |
Adjusted Return on Equity (ROE)
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).
2019 Calculations
1 ROE = 100 × Net earnings ÷ Total Abbott shareholders’ investment
= 100 × 3,687 ÷ 31,088 = 11.86%
2 Adjusted ROE = 100 × Adjusted net earnings ÷ Total Abbott shareholders’ investment
= 100 × 3,687 ÷ 31,088 = 11.86%
Profitability ratio | Description | The company |
---|---|---|
Adjusted ROE | A profitability ratio calculated as adjusted net income divided by shareholders’ equity. | Abbott Laboratories’s adjusted ROE improved from 2017 to 2018 and from 2018 to 2019. |
Adjusted Return on Assets (ROA)
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).
2019 Calculations
1 ROA = 100 × Net earnings ÷ Total assets
= 100 × 3,687 ÷ 67,887 = 5.43%
2 Adjusted ROA = 100 × Adjusted net earnings ÷ Total assets
= 100 × 3,687 ÷ 67,887 = 5.43%
Profitability ratio | Description | The company |
---|---|---|
Adjusted ROA | A profitability ratio calculated as adjusted net income divided by total assets. | Abbott Laboratories’s adjusted ROA improved from 2017 to 2018 and from 2018 to 2019. |